A study published recently in the International Journal of Pharmaceutics (https://www.sciencedirect.com/science/article/pii/S0378517324006392) shows, in particular, that Lenterra in-line measurements provide unique and rich information about the granulation process. This study demonstrates that the Lenterra Inline Rheometer (LIR) is capable of signaling the time instant at which the binding liquid is evenly distributed within the dry powder bed, which further reveals the initiation of particle agglomeration. Furthermore, the integrated force and force pulse magnitude (FPM) during the water addition phase are shown to be valuable measurements in approximating granule properties (such as specific energy and basic flowability energy) and predicting tablet tensile strength. The capability of predicting tablet tensile strength and compaction force from upstream data will minimize waste and eliminate operator trial runs to get the best compression machine settings.
“We are very excited to see that this joint UoB and GSK study demonstrated capabilities of Lenterra’s technology in prediction of table properties during high shear wet granulation. With this study we are even more confident that LIR will soon be widely recognized as a unique PAT tool for monitoring and control in pharmaceutical processing”, noted Vadim Stepaniuk, Director of Operations at Lenterra Inc.
Lenterra Inc., a New Jersey corporation, a developer of innovative micro-optical sensing technologies for mechanical forces in gases and liquids, his recently expanded its portfolio to powder characterization and powder flow measurements. Company’s flagship product – Lenterra Inline Rheometer (LIR) - is a unique instrument that employs patented Drag Force Flow (DFF) sensor and is capable to continuously monitor flow force, powder uniformity and temperature during processing. With years of experience, Lenterra is well skilled in addressing user’s individual flow characterization challenges, focusing on delivering a reliable solution for in-process material characterization, formulation development, scale-up, quality control, or other areas. More at www.lenterra.com.